Notch activation aggravates MASH by inhibiting eNOS transcription in methionine-choline-deficient diet-induced MASH mouse models, while pharmacological activation of eNOS can reduce liver inflammation and lipid deposition caused by Notch activation [128] (Fig. 4). The gene discussed is NOS3; the disease is metabolic dysfunction-associated steatohepatitis.